Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cardiff Oncology (NASDAQ:CRDF) through any online brokerage.
Other companies in Cardiff Oncology’s space includes: Kalaris Therapeutics Inc (NASDAQ:KLRS), Humacyte Inc (NASDAQ:HUMA), ProQR Therapeutics NV (NASDAQ:PRQR), Compugen Ltd (NASDAQ:CGEN) and Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP).
Cardiff Oncology has a consensus price target of $10.58.
The stock price for Cardiff Oncology (NASDAQ: CRDF) is $2.92 last updated January 23, 2026 at 7:56 PM EST.
There are no upcoming dividends for Cardiff Oncology.
Cardiff Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for Cardiff Oncology.
Cardiff Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.